For appointments

Call the office

Folsom, California Office: 916-983-4444

Call Now

Close

WHO:

Dr. Gish is a Hepatologist specializing in all forms of liver disease, liver cancer and liver transplant. Dr. Gish has partnered with TeleMed2U to provide telemedicine consultative services for patients with liver disease.

WHAT:

TeleMed2U is a telemedicine-based multi-specialty clinical practice increasing access to specialist providers providing, “healthcare anywhere and everywhere.” The telemedicine consultation will be conducted through our HIPAA and HITECH compliant platform. Connectivity testing will be done in advance to ensure you can connect via our telemedicine platform. Following the consultation, a clinical note will be provided including a summary of your liver consultation with Dr. Gish and his consultative recommendations.

COST:

Payment will be processed through an online secure transaction portal. The fees for consultative services are:

Initial 60 minute consultation per patient: $500.00
Follow Up 30 minute consultation per patient: $300.00

NEXT STEPS:

If you’d like to continue, please click Next to complete the form and we will contact you to schedule connectivity testing. During the test you will have the opportunity to determine the method of providing medical records, discuss appointment availability as well as discuss any additional questions that you have. If you are a healthcare facility interested in services, please complete the form and we can discuss the options that are right for you and your patients.

Email

Subject

Country

You should be aware of the general risks of transmitting information over the Internet, which may not use encryption. You should therefore not share any personal medical information that you would wish to be held confidential in a physician/patient or similar clinical relationship.

The information contained on this website is not intended, should not substitute for, or be used instead of, a clinical or therapeutic relationship with a health care professional who is fully familiar with the specifics of your case. The information on this site may assist you in your personal, general research but none of it constitutes the practice of medicine or any other health care profession.

Nothing in this site is intended as a recommendation or endorsement of any specific tests, products, procedures, healthcare provider, opinions, or other information that may be mentioned in this site. Any reliance on any information provided by the website personnel, others appearing on the site at the invitation of the website and/or other visitors to the site is solely at the user's risk.

E-mail correspondence with Dr. Robert G. Gish Consultants, LLC or any of its employees, or agents, does not create a physician/patient relationship between us or cause Dr. Gish to create or retain any medical records about you, monitor your care, or communicate with your own health care provider.

Always seek the advice of your physician or other qualified health care provider with any questions you have regarding your medical care. If you suspect that you may have a medical condition, or are seeking medical advice or treatment, we recommend that you consult a qualified health professional as soon as possible.

Powered by

Close Form

HHS Webinar 3/8/2017 - National Viral Hepatitis Action Plan

Feb 23, 2017

The HHS Office of HIV/AIDS and Infectious Disease Policy will host a webinar:

National Viral Hepatitis Action Plan 2017 – 2020 Wednesday, March 8, 2017, 3:00 – 4:30 PM ET.

» Register Now «

Join us in the fight as we move towards realizing the vision of the Action Plan:

The United States will be a place where new viral hepatitis infections have been eliminated, where all people with chronic hepatitis B and C know their status, and everyone with chronic hepatitis B and C has access to high quality health care and curative treatments, free from stigma and discrimination.

The webinar will include:

Key viral hepatitis facts and gaps in the United States
Overview of the National Viral Hepatitis Action Plan 2017 – 2020
What’s new/changed in the Action Plan
Perspectives from the Office of Minority Health on the importance of the Action Plan
Perspectives from national and state partners on the Action Plan

The National Viral Hepatitis Action Plan 2017-2020 (Action Plan) is posted and ready to share at www.hhs.gov/hepatitis. This Action Plan represents a new phase in our efforts and is the nation’s roadmap for addressing viral hepatitis in the United States.

Developed collaboratively by 23 federal partners from the U.S. Departments of Health and Human Services, Housing and Urban Development, Justice, and Veterans Affairs with input from non-federal stakeholders from a variety of sectors, the Action Plan recognizes that success cannot be achieved by federal action alone. The support and commitment of a broad mix of stakeholders from various sectors, both public and private is needed to achieve our national goals.

Everyone has a role to play in the battle against viral hepatitis in the United States. Register now for the webinar on March 8th and learn more about the critical role(s) of various partners and how you can become a part of our national response to hepatitis B and hepatitis C.

Metadata